SE392037B - Forfarande for framstellning av tabletter innehallande beta-laktamanti-biotikum - Google Patents

Forfarande for framstellning av tabletter innehallande beta-laktamanti-biotikum

Info

Publication number
SE392037B
SE392037B SE7409100A SE7409100A SE392037B SE 392037 B SE392037 B SE 392037B SE 7409100 A SE7409100 A SE 7409100A SE 7409100 A SE7409100 A SE 7409100A SE 392037 B SE392037 B SE 392037B
Authority
SE
Sweden
Prior art keywords
lactamanti
biotic
procedure
preparation
tablets containing
Prior art date
Application number
SE7409100A
Other languages
English (en)
Swedish (sv)
Other versions
SE7409100L (sv
Inventor
D C Sharland
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7409100L publication Critical patent/SE7409100L/xx
Publication of SE392037B publication Critical patent/SE392037B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7409100A 1973-07-12 1974-07-10 Forfarande for framstellning av tabletter innehallande beta-laktamanti-biotikum SE392037B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3321473A GB1466857A (en) 1973-07-12 1973-07-12 Urea tablets

Publications (2)

Publication Number Publication Date
SE7409100L SE7409100L (sv) 1975-01-13
SE392037B true SE392037B (sv) 1977-03-14

Family

ID=10350041

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7409100A SE392037B (sv) 1973-07-12 1974-07-10 Forfarande for framstellning av tabletter innehallande beta-laktamanti-biotikum

Country Status (12)

Country Link
US (1) US3996365A (da)
JP (1) JPS5714650B2 (da)
BE (1) BE817515A (da)
CA (1) CA1039653A (da)
DE (1) DE2433424A1 (da)
DK (1) DK146843C (da)
FR (1) FR2236485B1 (da)
GB (1) GB1466857A (da)
IE (1) IE39557B1 (da)
NL (1) NL178563C (da)
SE (1) SE392037B (da)
ZA (1) ZA744243B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007002924A1 (de) 2007-01-19 2008-07-24 Bayer Healthcare Ag ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679801A (en) * 1970-05-19 1972-07-25 Pfizer Aryl esters of {60 -carboxyarylmethyl-penicillins

Also Published As

Publication number Publication date
FR2236485A1 (da) 1975-02-07
DK146843C (da) 1984-07-16
IE39557B1 (en) 1978-11-08
SE7409100L (sv) 1975-01-13
ZA744243B (en) 1975-06-25
AU7113574A (en) 1976-01-15
CA1039653A (en) 1978-10-03
IE39557L (en) 1975-01-12
DK374674A (da) 1975-03-03
FR2236485B1 (da) 1978-07-21
GB1466857A (en) 1977-03-09
JPS5031025A (da) 1975-03-27
DK146843B (da) 1984-01-23
US3996365A (en) 1976-12-07
JPS5714650B2 (da) 1982-03-25
DE2433424A1 (de) 1975-01-30
NL178563C (nl) 1986-04-16
NL178563B (nl) 1985-11-18
NL7408986A (nl) 1975-01-14
BE817515A (fr) 1975-01-10

Similar Documents

Publication Publication Date Title
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
NO783636L (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE413405B (sv) Analogiforfarande for framstellning av pyridazinonforeningar
NO139219C (no) Fremgangsmaate for fremstilling av malonsyredinitril
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
SE7908625L (sv) Acetylglykosylmykofenolsyraforeningar for framstellning av glykosylmykofenolsyraforeningar
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE417969B (sv) Forfarande for framstellning av 3-metylencefalosporinforeningar
SE410470B (sv) Forfarande for framstellning av xyloslosning
FI55335B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-fluor-substituerade fenotiaziner
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
ZA732230B (en) Preparation of chemical compounds
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
RO72812A (ro) Procedeu pentru prepararea de biclorura fenilfosfonoasa
NO137750C (no) Fremgangsmaate til rensning av titantetraklorid
IT1001825B (it) Procedimento di preparazione di composti aromatici
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE413404B (sv) Forfarande for framstellning av pyrazolderivat
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
SE416648B (sv) Forfarande for framstellning av pyrazoler